More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering ...
Veppanu represents a scientific milestone as the first-ever proteolysis-targeting chimera (PROTAC) to receive FDA approval.
Trendy *and* hardworking — now that's what I'm talking about.
Everyday Health on MSN
Struggling with shiny skin? These 9 face washes tempered oily skin during testing
Looking for the best face wash for oily skin? We tested dozens of formulas to find the best cleansers for oil control, ...
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940 $93 million in cash provides runway through expected clinical proof-of-concept readout for KOMODO-1 SAN DIEGO, May 08, 2026 ...
Cash and cash equivalents of $10.2 million as of March 31, 2026 Favorable efficacy and safety reported in a small sample of triple negative breast cancer ("TNBC") ...
Enrollment proceeding in KOMODO-1 first-in-human clinical trial of BBI-940$93 million in cash provides runway through expected clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results